Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 26.404.985.735.293.71

What is the latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM ?

The latest EV/Core EBITDA ratio of SAMRAT PHARMACHEM is 26.40 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202426.40
Mar20234.98
Mar20225.73
Mar20215.29
Mar20203.71

How is EV/Core EBITDA of SAMRAT PHARMACHEM Trending?

Years EV/Core EBITDA % Change
Mar2024 26.4
430.12
Mar2023 4.98
-13.09
Mar2022 5.73
8.32
Mar2021 5.29
42.59
Mar2020 3.71 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EV/Core EBITDA ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹102.5 Cr -4.7% -9.9% -11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹119,988.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.1% -3.8% -13.3% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-4.7%

-9.9%

-11%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses